Moderna, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0QF.MU | 6547.TWO | 261780.KQ | 0A3M.IL | 0MGB.IL | VIR | |
|---|---|---|---|---|---|---|
| Market cap | 91.64B | 15.63B | 103.62B | 25.17B | 295.98B | 1.99B |
| P/E (TTM) | — | — | — | 5.1 | 52.2 | — |
| Forward P/E | — | 32.6 | — | 5.1 | — | -4.8 |
| Price/book | 15.2 | 4.4 | — | 1.1 | 8.4 | 2.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +978.11% | +42.31% | +44.97% | −13.17% | +93.74% | +129.88% |
| Today | +2.66% | −2.16% | −2.90% | +2.81% | +2.03% | +4.90% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 0QF.MU news ›Moderna Earnings Preview: The Melanoma Breakthrough Is Real, But $221 Is Way Too Much
Seeking Alpha - Moderna is rated Strong Sell at $220.83, with a working valuation of ~$60/share, implying 73% downside despite promising melanoma trial results. - MRNA's Phase 3 melanoma data with intismeran and Ke
Moderna (MRNA) Surges 13% to Record High Above $258 Ahead of Q3 Earnings
FX Leaders is the leading provider of real-time market news, market analysis, trade ideas, trade recommendations and forex signals for Forex trading. FXL has become a gateway to the Forex market for millions of traders worldwide. The FX…
Universal Health Services, Tenet Healthcare, Moderna, Novavax, and Intuitive Surgical stocks trade up, what you need to know
The Globe and Mail Universal Health Services, Tenet Healthcare, Moderna, Novavax, and Intuitive Surgical stocks trade up, what you need to know A number of stocks jumped in t
Moderna Clears $258 to Set a Fresh 52-Week High
As seen on the 24/7 Wall St. homepage on November 4, 2026. Moderna cleared $258.38, a fresh 52-week high and 5.11% above the peak it set on October 21. The $103.2 billion vaccine maker keeps resetting its own ceiling faster than two weeks…
Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting
Nasdaq Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting Nov 4, 2026 9:50am EST Initial Phase 1/2 data highlight t
Moderna Soars 8% on Early Multiple Myeloma Data for Its Three-in-One mRNA Therapy
jarun011 from Getty Images Pro and Pavel Danilyuk from Pexels via Canva Moderna (MRNA) stock is up 8% today after early data on its experimental multiple myeloma therapy, mRNA-2808. mRNA-2808 gets the body to make three T-cell engagers.…
Which Dates Could Move Moderna Stock Most?
Moderna (MRNA) stock returned 713.1% over the year to November 2, 2026, compared to 11.5% for the S&P 500. Yet management expects revenue to grow by up to 10% in 2026, a forecast that assumes no sales of mCOMBRIAX, its combined flu and…
Moderna rated Strong Sell at $220.83 despite positive melanoma trial, citing 73% downside risk.
Moderna's stock is rated Strong Sell at $220.83, with a valuation around $60 per share, implying a 73% downside. This is despite promising Phase 3 melanoma trial results showing a 42% reduction in relapse or death when using intismeran…
ELEVA – Moderna 2020, GDA Join Forces To Streamline Italian Retail Logistics
Headquartered in Salerno with €1 million in share capital, the 50/50 joint venture brings together a combined network of 409 stores across the regions of Campania, Calabria, Basilicata, Puglia, Lazio, Abruzzo and Molise. Together, the two…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- 247wallst.com23
- marketscreener.com22
- seekingalpha.com19
- fool.com18
- theglobeandmail.com18
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.